2003Fundamental and Clinical PharmacologyRequires access

Treatment of cutaneous larva migrans and Toxocara infection

Éric Caumes

Open publisher page 63 citations

Abstract

The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin. The efficacy of these agents varies according to the helminthic disease.

About this research paper

What this paper is about

The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin. The efficacy of these agents varies according to the helminthic disease.

Why it matters

OpenAlex reports 63 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin. The efficacy of these agents varies according to the helminthic disease.

Key concepts: Larva migrans, Cutaneous larva migrans, Larva, Visceral larva migrans, Helminthiasis, Biology, Helminths, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of cutaneous larva migrans and Toxocara infection — Research Paper | ScholarLens